logo
  • Home
  • About
    • Leadership
    • Scientific Advisors
    • Board
  • Science
    • Targeting the DDR
    • Clinical Trials
    • Pipeline
  • Investors & Partners
    • Our Investors
    • Our Partners
    • Merck KGaA
    • Novartis
  • Careers
    • Our Opportunities
    • Our Testimonials
    • Our Benefits
    • Core Values
  • News & Events
    • Press release
    • Media coverage
    • Conferences
  • Contact Us
artios header image

Press release

Artios Pharma wins Life Science Young Company of the Year and UK Private Finance Raise at the Biotech and Money Annual Awards 2017

15 September 2017 | Press release

Article-2-400×400
Artios Pharma appoints Dr Graeme Smith as Chief Scientific Officer

4 September 2017 | Press release

Graeme
Artios signs research collaboration with Masaryk University to develop novel cancer treatments targeting DNA nucleases in the DDR

12 June 2017 | Press release

Article-6-400×400
Artios announces formation of world-leading Scientific Advisory Board

8 June 2017 | Press release

cube-hero-front-300×300
Artios Strengthens Management Team with the Appointment of Dr Simon Boulton as Vice President Science Strategy

2 November 2016 | Press release

simon
Artios Pharma Company Launch and Fundraising of $33.2 Million to Focus on Novel DNA Damage Response (DDR) Cancer Therapies

21 September 2016 | Press release

Article-3-400×400
« Previous 1 2 3
logo

Quick Links

  • Homepage
  • About
  • Science
  • Our Investors
  • Our Partners
  • News & Events
  • Careers
  • Contact Us

Contact

UK Office: +44 (0)1223 867 900
General enquiries: info@artios.com
Careers: HR@artios.com
Finance: Accounts@artios.com

Our career opportunities

Our careers
© Artios Pharma 2022 | Website by Granite 5
Follow on twitter Follow on LinkedIn

Terms & conditions | Privacy policy | Site map

We use cookies to collect data, please see our privacy policy.